Inventor

EVERS ANDREAS

DE32 patents

⚠️ This page may combine multiple inventors who share the name “EVERS ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EVERS ANDREAS

SANOFI SA

Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists

Non-acylated exendin-4 peptide analogues

Exendin-4 derivatives as dual GLP1/glucagon agonists

Exendin-4 peptide analogues

Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists

Dual GLP-1/GIP receptor agonists

Dual GLP-1/glucagon receptor agonists

Functionalized exendin-4 derivatives

Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists

Compounds as peptidic GLP1/glucagon/GIP receptor agonists

Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists

Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists

Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4

Dual GLP-1/glucagon receptor agonists derived from exendin-4

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

FGF21 compound / GLP-1R agonist combinations with optimized activity ratio

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid

Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid

Exendin-4 derivatives as dual GLP1/glucagon agonists

Functionalized Exendin-4 derivatives

Exendin-4 derivatives as selective glucagon receptor agonists

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists

Pyrazole derivatives and their use as LPAR5 antagonists

Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation

Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals

Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate

KALLUS CHRISTOPHER

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

Macrocyclic urea and sulfamide derivatives as inhibitors of tafia

Urea and sulfamide derivatives as inhibitors of TAFIa

ANTAROS MEDICAL AB

Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes